Vancity announces new Chief Technology and Information 7-03-2023, 00:59

InvestChile's Portfolio Reached US $28,345 Million in 2022, Together With US $29,000 Million in Green Hydrogen Projects 16-02-2023, 22:00

Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study 21-04-2023, 03:01